Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Maravai Lifesciences Holdings (MRVI) Shares Outstanding (Diluted Average): 2019-2024

Historic Shares Outstanding (Diluted Average) for Maravai Lifesciences Holdings (MRVI) over the last 6 years, with Dec 2024 value amounting to $137.9 million.

  • Maravai Lifesciences Holdings' Shares Outstanding (Diluted Average) rose 2.21% to $144.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $144.7 million, marking a year-over-year increase of 2.21%. This contributed to the annual value of $137.9 million for FY2024, which is 4.54% up from last year.
  • As of FY2024, Maravai Lifesciences Holdings' Shares Outstanding (Diluted Average) stood at $137.9 million, which was up 4.54% from $131.9 million recorded in FY2023.
  • Over the past 5 years, Maravai Lifesciences Holdings' Shares Outstanding (Diluted Average) peaked at $257.8 million during FY2021, and registered a low of $28.9 million during FY2020.
  • Over the past 3 years, Maravai Lifesciences Holdings' median Shares Outstanding (Diluted Average) value was $137.9 million (recorded in 2024), while the average stood at $175.0 million.
  • Its Shares Outstanding (Diluted Average) has fluctuated over the past 5 years, first tumbled by 88.62% in 2020, then skyrocketed by 791.81% in 2021.
  • Yearly analysis of 5 years shows Maravai Lifesciences Holdings' Shares Outstanding (Diluted Average) stood at $28.9 million in 2020, then spiked by 791.81% to $257.8 million in 2021, then decreased by 0.96% to $255.3 million in 2022, then crashed by 48.33% to $131.9 million in 2023, then grew by 4.54% to $137.9 million in 2024.